Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up

(2018) Lise M.A. De Strooper et al.   INTERNATIONAL JOURNAL OF CANCER

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study

(2016) Sarah Preisler et al.   BMC CANCER

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women

(2016) Roosmarijn Luttmer et al.   BRITISH JOURNAL OF CANCER

Management of high-risk HPV-positive women for detection of cervical (pre)cancer

(2016) Roosmarijn Luttmer et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Validation of the FAM19A4 / mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women

(2016) Lise M.A. De Strooper et al.   GYNECOLOGIC ONCOLOGY

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays

(2016) Matejka Rebolj et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening

(2014) Nicolas Wentzensen et al.   CANCER CYTOPATHOLOGY

Methylation Analysis of the FAM19A4 Gene in Cervical Scrapes Is Highly Efficient in Detecting Cervical Carcinomas and Advanced CIN2/3 Lesions

(2014) L. M. A. De Strooper et al.   Cancer Prevention Research

CADM1,MALandmiR124-2methylation analysis in cervical scrapes to detect cervical and endometrial cancer

(2014) Lise M A De Strooper et al.   JOURNAL OF CLINICAL PATHOLOGY

Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection

(2011) Mariska Bierkens et al.   INTERNATIONAL JOURNAL OF CANCER

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER